Regenerative Medicines: Bone and Joint Applications

Jun 2023| PHM032F| BCC Publishing

Report Highlights

The global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.

Report Includes

  • 36 data tables and 30 additional tables
  • An up-to-date review and in-depth assessment of the global markets for regenerative medicine in bone and joint applications
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for regenerative medicine for bone and joint applications market, and corresponding market share analysis based on the type of technology, application, and region
  • Highlights of the importance of biomaterials, stem cell therapy, tissue engineering, and emerging/upcoming technologies (including bioprinting) in the regenerative medicine industry, along with the long-term impacts of regenerative medicine technologies, both existing and in developmental stage
  • Country specific data analysis and market growth forecasts for the U.S., Canada, Germany, the UK, France, Italy, Russia, Spain, Australia, Japan, China and India
  • Discussion of major growth drivers and restraints, technology advancements, product innovations and regulatory aspects that will shape the market for regenerative medicine for bone and joint applications as a basis for projecting demand in the next few years (2023-2028)
  • Identification of the companies best positioned to meet this demand owing to or in conjunction with their proprietary technologies, product launches, and other strategic advantages
  • Holistic review of the impact of COVID-19 and other economic and demographic factors affecting the market growth in the analysis period
  • A relevant patent analysis with the number of patents registered/approved, ongoing industry clinical trials, and recent mergers, acquisitions, and collaboration agreements in the regenerative medicine industry
  • Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on global R&D activities, market growth strategies, and company revenue share analysis
  • Identification of leading and emerging competitors in the global regenerative medicine market, and analysis of competitive landscape based on recent developments and segmental revenues
  • Company profiles descriptions of the major market players, including Smith & Nephew Plc, DePuy Synthes, Medtronic plc, Stryker Corp., Bioventus, Zimmer Biomet, Anika Therapeutics, Baxter Intl., and CONMED Corp.

Report Scope

The report explains critical trends in the regenerative medicine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.

This study looks at most of the systems affected by factors such as R&D spending and increasing competition and new technologies.

This report also covers merger and acquisition strategies and collaborations, as well as the strengths and weaknesses of each strategy type.

The market has also been analyzed based on regenerative medicine for bone and joint applications. Categories considered in this report include allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases, and others.

The report provides information to all market players, potential entrants, government agencies, and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Frequently Asked Questions (FAQs)

The regenerative medicines for bones and joint and applications market is projected to grow from $9.6 billion in 2022 to $18.9 billion in 2028, at a compound annual growth rate (CAGR) of 12.1% during the forecast period.
The key factors driving the growth of the market includes.
  • Rising number of bones and joint disorders and orthopedic surgeries.
  • Technological advancements and innovations.
  • Increasing geriatric population.
  • Increasing healthcare expenditure and investment for regenerative medicines by pharma companies.
  • Increasing product approvals and launches.
  • R&D for stem and gene therapies.
The regenerative medicines for bones and joint and applications market is segmented on the basis of technology type-Biomaterials, Tissue Engineering and Stem cell therapy. And on the basis of application-Bone Graft Substitute, Osteoarticular diseases, Allogenic bones, Autogenic bones and others and by region.
Biomaterials will dominate the market by the end of 2028.
Key companies in the market includes Smith & Nephew, DePuy Synthes, Medtronic PLC., Stryker, Anika Therapeutics, Bioventus.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $9.6 billion
Market size forecast $18.9 billion
Growth rate CAGR of 12.1% during the forecast period of 2023-2028
Units considered $ Millions
Segments covered By Technology, Application, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, the UK, Germany, France, Italy, Spain, Russia, Japan, China, India, Australia etc.
Key Market Drivers
  • Growing Number of Bone and Joint Disorders and Orthopedic Surgeries
  • Increasing Expenditures for Health Care and Investments in Regenerative Medicines
  • Increasing Geriatric Population
  • Increasing Product Approvals and Launches
  • R&D for Stem and Gene Therapies
Companies studied
  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BAXTER
  • BIOVENTUS
  • CONMED CORP.
  • DEPUY SYNTHES PRODUCTS INC. (PART OF JOHNSON & JOHNSON)
  • MEDTRONIC
  • ROYAL BIOLOGICS
  • SEIKAGAKU CORP.
  • SMITH & NEPHEW PLC
  • STRYKER CORP.
  • ZIMMER BIOMET

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Regenerative Medicines: Bone and Joint Applications147Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background6Free
Chapter- 4: Emerging/Upcoming Technologies in the Market7Free
Chapter- 5: Market Dynamics7Free
Chapter- 6: Market Breakdown by Technology16Free
Chapter- 7: Market Breakdown by Application13Free
Chapter- 8: Market Breakdown by Region25Free
Chapter- 9: Regulatory Aspects4Free
Chapter- 10: Patent Review/New Developments6Free
Chapter- 11: Competitive Landscape7Free
Chapter- 12: Company Profiles44Free
Chapter- 13: Appendix: List of Acronyms1Free
Published - Jul-2022| Analyst - BCC Publishing| Code - PHM032E

Report Highlights

The global regenerative medicine for bone and joint applications market should reach $16.4 billion by 2027 from $9.4 billion in 2022 at a compound annual growth rate (CAGR) of 11.6% for the forecast period of 2022 to 2027.

Report Includes

  • 51 tables
  • An overview of the global market for regenerative medicines for bone and joint applications
  • Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
  • Characterization and quantification of market potential for regenerative medicines by technology, application, and region
  • Coverage and discussion on regulatory delays due to COVID-19, clinical trials and product launches of the industry
  • Description of principle approaches to regenerative medicine and discussion on importance of scaffolding in tissue engineering
  • Information on major drivers and regional dynamics of the market and current trends within the industry
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
  • Company profiles of major players, including Anika Therapeutics, Conmed Corp., Johnson & Johnson and Stryker Corp.
Published - May-2015| Analyst - Kevin Gainer| Code - PHM032D

Report Highlights

The U.S. market for regenerative medicine products used in bone and joint applications is expected to grow at a compound annual growth rate (CAGR) of 6.8% from $2.9 billion in 2015 to nearly $4.1 billion in 2020.

Report Includes

  • An overview of the market for regenerative medicines in bone and joint applications, whose key objectives are the utilization of living cells to repair or replace body tissue damaged by injury, disease, or the aging process.
  • Analyses of market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
  • Coverage of other regenerative applications, such as dental, neurologic, organ regeneration, cardiovascular, urologic, diabetes, and wound care, as well as stem cell research.
  • Identification of market drivers, including an increase in diseases and disorders that will benefit from these products, primarily arthritis, osteoporosis, and various types of bone and joint trauma (e.g., hip fractures, knee injuries); increasing use of nonautograft products by physicians; and innovative devices that incorporate bone- and cartilage-growth-stimulating agents in a regenerative appliance.
  • Descriptions of products, such as bone and cartilage grafting and regenerative products derived from autologous, allogeneic, and synthetic sources, as well as electrical stimulators for bone growth and regenerative cartilage products.
Published - Jun-2013| Analyst - Kevin Gainer| Code - PHM032C

Report Highlights

The U.S. market for regenerative medicine products used in bone and joint applications was estimated to total $2.72 billion in 2012 and is projected to increase to $2.73 billion in 2013. The market should total nearly $3.9 billion by 2018 and have a five-year compound annual growth rate (CAGR) of 7.3%.

Report Includes

  • An overview of the market for regenerative medicines in bone and joint applications, whose key objectives are the utilization of living cells to repair or replace body tissue damaged by injury, disease, or the aging process.
  • Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Coverage of other regenerative applications, such as dental, neurologic, organ regeneration, cardiovascular, urologic, diabetes, and wound care, as well as stem cell research.
  • Identification of market drivers, including an increase in diseases and disorders that will benefit from these products, primarily arthritis, osteoporosis, and various types of bone and joint trauma (e.g., hip fractures, knee injuries); increasing use of nonautograft products by physicians; and innovative devices that incorporate bone- and cartilage-growth-stimulating agents in a regenerative appliance.
  • Descriptions of products, such as bone and cartilage grafting and regenerative products derived from autologous, allogeneic, and synthetic sources, as well as electrical stimulators for bone growth and regenerative cartilage products.

Published - Oct-2009| Analyst - Kevin Gainer| Code - PHM032B

Report Highlights

  • Overall sales in the regenerative medicine productsmarket were worth $1.1 billion in 2007, and remained flat into 2009. By 2014, sales are projected to increase to nearly $1.8 billion, for a 5-year compound annual growth rate (CAGR) of 8.6%.
  • The largest segment in the market, bone replacement/grafting, was valued at $714  million in 2007. This also has increased only slightly into 2009 but is projected to reach $979  million in 2014, for a 5-year CAGR of 6.3%.
  • Sales in the bone growth stimulators product segment were worth $321  million in 2007, and were to increase slightly into 2009.  By 2014, however, they are projected to increase to $578  million, for a 5-year CAGR of 11.9%.
Published - Jul-2003| Analyst - Lynn Gray| Code - PHM032A

Report Highlights

  • The total U.S. market for bone and joint applications of regenerative medicine is projected to rise at an average annual growth rate of 8.5% to reach $1.4 billion in 2007.
  • Regenerative medicine refers to technologies that repair or replace diseased or defective tissues or organs. The main types of regenerative medicine utilize products naturally occurring in the body, such as genes and proteins (antibodies, growth factors, hormones); cells and tissues; embryonic stem cells, and biomaterials. At present, most regenerative medicines on the market fall into the first category and include protein-based drugs and therapies containing human cells. However, there are a few products based on tissue engineering. This technology, which promises to be the most exciting and fastest growing sector of regenerative medicine in the near future, is the primary focus of this report. Tissue engineering technologies discussed include matrices and scaffolds, in vitro and in vivo technologies, and novel materials, which include those utilizing nanotechnology (atomic-scale engineering) of inorganic substances that meld with human tissues.

Regenerative Medicines: Bone and Joint Applications

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS